Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Healthpoint
The objective of this study is to examine the durability of previous target wound closures, identify new test article-related adverse events, record new target wound closures, and examine ongoing adverse events not resolved in subjects who participated in HP 802-247-09-015.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Provide informed consent
Willing to comply with protocol instructions, including allowing all study assessments.
Subject was randomized in HP 802-247-09-015 and received at least one application of a test article, whether active or placebo.
Subject has ended their participation in HP 802-247-09-015 by virtue of completing the study, or by dropping out prior to completion.
You may not be if
Subjects who refuse to provide written informed consent will be excluded from this trial.
